FTC supports CREATES Act before House antitrust subcommittee

The head of the Federal Trade Commission's bureau of competition testified yesterday that a bill before Congress would help tackle the problem of drugmakers using the Food & Drug Administration approval process anticompetitively.

Unlock unlimited access to all Global Competition Review content